RESEARCH ARTICLE

Aminaphtone for Light Bleeding in Patients Under Oral Anticoagulation

The Open Cardiovascular Medicine Journal 18 June 2010 RESEARCH ARTICLE DOI: 10.2174/1874192401004010146

Abstract

Background:

Bleeding is a common complication of oral anticoagulation therapy.

Objective:

The present study evaluated the use of aminaphtone in patients with minor bleeding while taking warfarin.

Methods:

Seven patients suffering from bleeding of the nose and gums, who were taking therapeutic doses of warfarin, were included in the study.

Results:

The patients were prescribed 75 mg aminaphtone twice daily. For 5 of these patients the bleeding was controlled within 48 h, for 1, within 96 h and for the other, a satisfactory reduction was obtained.

Conclusion:

Patients with minor bleeding during treatment using oral anticoagulation, who are free from risk of other complications, can benefit from the use of aminaphtone as an initial therapeutic option.

Keywords: Bleeding, Oral Anticoagulation, Warfarin, Aminaphtone, Treatment .
Fulltext HTML PDF
1800
1801
1802
1803
1804